{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:15:18Z","timestamp":1791281718973,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jconrel.2008.12.006","type":"journal-article","created":{"date-parts":[[2008,12,25]],"date-time":"2008-12-25T05:13:25Z","timestamp":1230182005000},"page":"113-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins"],"prefix":"10.1016","volume":"135","author":[{"given":"James E.","family":"Stefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Honey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Kyazike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark Q.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Edmunds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2008.12.006_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases","volume":"57","author":"Brady","year":"2006","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2008.12.006_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1096\/fj.01-0343fje","article-title":"Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium","volume":"16","author":"Muruganandam","year":"2002","journal-title":"Faseb J."},{"issue":"2","key":"10.1016\/j.jconrel.2008.12.006_bib3","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/j.jconrel.2006.09.050","article-title":"A novel opportunity for targeted drug delivery to the brain","volume":"116","author":"Gaillard","year":"2006","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.jconrel.2008.12.006_bib4","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0702170104","article-title":"Targeted delivery of proteins across the blood-brain barrier","volume":"104","author":"Spencer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jconrel.2008.12.006_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2006.12.012","article-title":"Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain","volume":"118","author":"Kreuter","year":"2007","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2008.12.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.05.022","article-title":"Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123","volume":"122","author":"Tosi","year":"2007","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2008.12.006_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2008.03.007","article-title":"Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26","volume":"128","author":"Pang","year":"2008","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2008.12.006_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/bit.21602","article-title":"Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier","volume":"99","author":"Boado","year":"2008","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.jconrel.2008.12.006_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2007.04.001","article-title":"Blood-brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses","volume":"122","author":"Pardridge","year":"2007","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2008.12.006_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2007.12.018","article-title":"Potential of solid lipid nanoparticles in brain targeting","volume":"127","author":"Kaur","year":"2008","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2008.12.006_bib11","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1073\/pnas.0308728100","article-title":"Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice","volume":"101","author":"LeBowitz","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl 2","key":"10.1016\/j.jconrel.2008.12.006_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1023\/A:1012423924648","article-title":"Renal pathological changes in Fabry disease","volume":"24","author":"Sessa","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.jconrel.2008.12.006_bib13","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1073\/pnas.0711515105","article-title":"Podocytes use FcRn to clear IgG from the glomerular basement membrane","volume":"105","author":"Akilesh","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.jconrel.2008.12.006_bib14","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/intimm\/10.9.1289","article-title":"Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice","volume":"10","author":"Borvak","year":"1998","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2008.12.006_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2008.12.006_bib16","first-page":"235","article-title":"Plasmalemmal vesicles are involved in transendothelial transport of albumin, lysosomal enzymes and mannose 6-phosphate receptor fragments in capillary endothelium","volume":"51","author":"Willemsen","year":"1990","journal-title":"Eur. J. Cell Biol."},{"issue":"38","key":"10.1016\/j.jconrel.2008.12.006_bib17","doi-asserted-by":"crossref","first-page":"35035","DOI":"10.1074\/jbc.M205854200","article-title":"Albumin binding as a general strategy for improving the pharmacokinetics of proteins","volume":"277","author":"Dennis","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2008.12.006_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-8674(78)90102-2","article-title":"Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells","volume":"15","author":"Achord","year":"1978","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jconrel.2008.12.006_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0304-4165(81)90474-8","article-title":"Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation","volume":"673","author":"Furbish","year":"1981","journal-title":"Biochim. Biophys. Acta"},{"issue":"41","key":"10.1016\/j.jconrel.2008.12.006_bib20","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0607053103","article-title":"Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors","volume":"103","author":"Sly","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2008.12.006_bib21","first-page":"3","article-title":"Enzyme replacement therapy in a murine model of Morquio A syndrome","volume":"3","author":"Tomatsu","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2008.12.006_bib22","unstructured":"P. Calias, Miller, R., Modification of biopolymers for improved drug delivery, US Patent US6749865 B22004."},{"issue":"6","key":"10.1016\/j.jconrel.2008.12.006_bib23","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1021\/bc050239a","article-title":"Synthesis and evaluation of hydrolyzable hyaluronan-tethered bupivacaine delivery systems","volume":"16","author":"Gianolio","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2008.12.006_bib24","first-page":"17","volume":"vol. 2","author":"Bishop","year":"1980"},{"issue":"1","key":"10.1016\/j.jconrel.2008.12.006_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.jconrel.2008.12.006_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/glycob\/cwg034","article-title":"A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease","volume":"13","author":"Lee","year":"2003","journal-title":"Glycobiology"},{"issue":"3","key":"10.1016\/j.jconrel.2008.12.006_bib27","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1042\/bj2140951","article-title":"The metabolism in vitro of human low-density lipoprotein by the human hepatoma cell line Hep G2","volume":"214","author":"Havekes","year":"1983","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.jconrel.2008.12.006_bib28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1074\/jbc.270.3.1015","article-title":"Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor\/diphtheria toxin receptor and inhibits specifically its mitogenic activity","volume":"270","author":"Mitamura","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"43","key":"10.1016\/j.jconrel.2008.12.006_bib29","doi-asserted-by":"crossref","first-page":"27084","DOI":"10.1074\/jbc.272.43.27084","article-title":"Structure-function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis","volume":"272","author":"Mitamura","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2008.12.006_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0014-5793(96)00863-0","article-title":"Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal system","volume":"393","author":"Kase","year":"1996","journal-title":"FEBS Lett."},{"issue":"13","key":"10.1016\/j.jconrel.2008.12.006_bib31","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1111\/j.1742-4658.2007.05873.x","article-title":"Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity","volume":"274","author":"Remmel","year":"2007","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.jconrel.2008.12.006_bib32","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1194\/jlr.M500547-JLR200","article-title":"Saposin B binds and transfers phospholipids","volume":"47","author":"Ciaffoni","year":"2006","journal-title":"J. Lipid Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365908008043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365908008043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:22:20Z","timestamp":1759159340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365908008043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0168365908008043"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2008.12.006","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2008.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}